Biohaven shares clinical data on epilepsy drug opakalim

Go back to Biohaven shares clinical data on epilepsy drug opakalim
(NYSE: BHVN) Delayed: 14.78 -0.72 (4.65%)
Previous Close $15.50    52 Week High
Open $15.04    52 Week Low
Day High $15.80    P/E N/A 
Day Low $14.75    EPS
Volume 2,482,915